In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae

Marcelo Sandoval-Denis, F. Javier Pastor, Javier Capilla, Deanna A. Sutton, Annette W. Fothergill, Josep Guarro

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The in vitro activities of fluconazole (FLC), amphotericin B (AmB) and caspofungin (CSP) were evaluated against three isolates of Candida lusitaniae using time-kill curves. AmB showed in vitro fungicidal activity, whilst FLC and CSP exerted mainly strain-dependent fungistatic activity. The in vivo efficacies of the three drugs were evaluated in a murine model of disseminated infection. The doses administered were FLC 50 mg/kg/day, AmB 0.8 mg/kg/day and CSP 5 mg/kg/day. All three drugs were able to reduce the fungal burden in the kidneys of infected mice, with AmB showing the highest efficacy, followed by CSP. At least in this model, FLC, AmB and CSP are good candidates for treating invasive infections by C. lusitaniae.

Original languageEnglish (US)
Pages (from-to)161-164
Number of pages4
JournalInternational Journal of Antimicrobial Agents
Volume43
Issue number2
DOIs
StatePublished - Feb 1 2014

Keywords

  • Animal model
  • Antifungal therapy
  • Candida lusitaniae
  • Fungal infection
  • Murine

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae'. Together they form a unique fingerprint.

Cite this